drugset / Trial / NCT05790941

Proof of Concept Study of Latanoprost/Minoxidil (ANR-001.1) Topical Formulation

NCT05790941

Phase 0 Unknown 12 enrolled Aneira Pharma, Inc.
RandomizedSingle-groupSingle-blindTreatment

Summary

Study to Evaluate the safety and efficacy of a Latanoprost/Minoxidil formulation vs. placebo for the treatment of hypotrichosis of the eyebrows.

Timeline

Start
2023-03-11
Primary completion
2023-06-30
Completion
2023-06-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Latanoprost Small molecule Topical
Subject Minoxidil Small molecule Topical

Indications